Evidation, co-founded by Stanford University and GE Ventures, has picked up series E funding at a $1bn valuation.
Evidation Health, a US-based health data analysis provider, has picked up $153m in a series E round co-led by healthcare consortium Kaiser Permanente’s Group Trust.
The round was co-led by Omers Growth Equity, a fund managed by pension fund Ontario Municipal Employees Retirement System, and included McKesson Ventures, the corporate venturing arm of medical supplies distributor McKesson, as well as venture capital firm B Capital Group.
Evidation’s technology platform, Achievement, records raw behaviour data such as speech and…
